FDAnews Drug Daily Bulletin

Amgen’s TVEC Vaccine Shows Promise in Regional Melanoma, Greater Benefit and Applicability in Question

Sept. 4, 2012
A A
Amgen’s therapeutic vaccine, TVEC, shows promise in controlling regional melanoma, experts told BioPharm Insight. However, they questioned whether the injectable therapy would be effective in treating distal tumors in the liver, brain, and lungs.
Financial Times